Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022

オーソバイオロジクスの世界市場予測(~2022年):関節内補充療法、合成オーソバイオロジクス、DBM、BMP、PRP、BMAC、同種移植片

◆タイトル:Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022
◆商品コード:MAM-MD-5606
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年9月27日
◆ページ数:158
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、オーソバイオロジクスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、製品別分析、用途別分析、需要先別分析、オーソバイオロジクスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・オーソバイオロジクスの世界市場:市場インサイト
・オーソバイオロジクスの世界市場:市場概観/市場動向
・オーソバイオロジクスの世界市場:産業動向
・オーソバイオロジクスの世界市場:製品別分析/市場規模
・オーソバイオロジクスの世界市場:用途別分析/市場規模
・オーソバイオロジクスの世界市場:需要先別分析/市場規模
・オーソバイオロジクスのアジア市場規模予測
・オーソバイオロジクスのヨーロッパ市場規模予測
・オーソバイオロジクスのアメリカ市場規模予測
・オーソバイオロジクスの世界市場動向
・オーソバイオロジクスの世界市場:競争状況
・オーソバイオロジクスの世界市場:関連企業分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

“The orthobiologics market projected to grow at a CAGR of 5.4%.”The global orthobiologics market is projected to reach USD 6.06 billion by 2022 from USD 4.66 billion in 2017, at a CAGR of 5.4%. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the orthobiologics market. However, high cost pertaining to orthobiologics based treatment is the major factor restraining the market growth to a certain extent.

“The PRP segment is expected to grow at the highest rate during the forecast period.”
The PRP market is expected to grow at the highest CAGR during the forecast period. The advantages of PRP (such as reduced hospital stay) over other products used in bone stimulation are expected to drive the growth of this market. Additionally, the increasing use of PRP in sports injuries and the growing number of clinical trials to expand the application areas of PRP are expected to support the growth of this market during the forecast period.

“The spinal fusion segment is expected to grow at the highest CAGR.”
Based on applications, the orthobiologics market has been categorized into the following segments: fracture recovery, osteoarthritis & degenerative arthritis, spinal fusion, soft-tissue injuries, and maxillofacial & dental applications. Amongst these, the spinal fusion segment is expected to grow at highest CAGR during the forecast period owing to factors such as the rising number of spinal fusion procedures, increasing adoption of allografts & BMAC as part of adjuvant therapy during spinal fusion procedures, & extensive use of stem cells for bone regeneration and bone grafting procedures.

“Hospitals, orthopedic clinics, and ambulatory care centers are expected to be the fastest-growing segment.”
On the basis of end user, the market is segmented into hospitals, orthopedic clinics, and ambulatory care centers; research & academic institutes; and dental clinics and facilities. The hospitals, orthopedic clinics, and ambulatory care centers segment is expected to grow at the highest rate during the forecast period. This can be attributed to the growing geriatric population (coupled with the increasing number of spinal fusion surgeries performed); road accident injuries and bone fractures; growing prevalence of spinal disorders; and growing awareness of products.

“Asia Pacific is expected to register the highest growth rate in the orthobiologics market.”
Geographically, the orthobiologics market is segmented into North America, Europe, Asia Pacific, and RoW. The Asia Pacific market is expected to register the highest growth rate during the forecast period. The presence of a large geriatric and target patient population, high incidence of osteoarthritis and obesity, increasing government spending on healthcare, and improving healthcare infrastructure are some of the major factors driving the growth of the Asia Pacific orthobiologics market.

Breakdown of supply-side primary interviews:
• By Company Type – Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
• By Designation – – C-level – 26%, Director level – 30%, Others – 44%
• By Region – North America – 34%, Europe – 26%, APAC – 23%, RoW – 17%

The major players in the market included are DePuy Synthes, Medtronic, Stryker, Zimmer Biomet, Harvest Technologies, and Globus Medical.

Research Coverage
This report studies the orthobiologics market based on product, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends. The report forecasts the revenue of the market segments with respect to four main regions and respective countries.

Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the orthobiologics market, and high-growth regions and their drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKETS COVERED 14
1.3.1 YEARS CONSIDERED FOR THE STUDY 14
1.4 CURRENCY 15
1.5 RESEARCH LIMITATIONS 15
1.6 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 RESEARCH DATA 16
2.1.1 SECONDARY DATA 17
2.1.2 PRIMARY DATA 18
2.2 MARKET SIZE ESTIMATION METHODOLOGY 19
2.2.1 BOTTOM-UP APPROACH 19
2.2.2 TOP-DOWN APPROACH 20
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.4 RESEARCH ASSUMPTIONS 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 27
4.1 GLOBAL ORTHOBIOLOGICS MARKET OVERVIEW 27
4.2 GLOBAL ORTHOBIOLOGICS MARKET: BY PRODUCT (2017 VS. 2022) 28
4.3 ORTHOBIOLOGICS MARKET: REGIONAL ANALYSIS (2017–2022) 29
4.4 ORTHOBIOLOGICS MARKET: BY APPLICATION, 2017 30
4.5 GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END USER 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 MARKET DRIVERS 33
5.2.1.1 Increasing incidence of sports injuries and road accidents 33
5.2.1.2 Increasing incidence of spinal diseases/disorders 34
5.2.1.3 Rising geriatric and obese population 34
5.2.1.4 Growing patient preference for minimally invasive procedures 35
5.2.2 MARKET RESTRAINT 36
5.2.2.1 High cost associated with orthobiologics-based treatments 36
5.2.3 GROWTH OPPORTUNITIES 36
5.2.3.1 Emerging markets 36
5.2.3.2 Increasing use of PRP in other applications 37
5.2.4 MARKET CHALLENGES 37
5.2.4.1 Lawsuits filed against major market players affecting their brand value 37
5.2.4.2 Side effects associated with BMP-based treatments 37
5.3 KEY INDUSTRY TREND 38
6 ORTHOBIOLOGICS MARKET, BY PRODUCT 39
6.1 INTRODUCTION 40
6.2 VISCOSUPPLEMENTATION PRODUCTS 41
6.3 DEMINERALIZED BONE MATRICES 42
6.4 SYNTHETIC ORTHOBIOLOGICS 43
6.5 BONE MORPHOGENIC PROTEIN 44
6.6 ALLOGRAFTS 45
6.7 PLASMA-RICH PROTEIN 46
6.8 BONE MARROW ASPIRATE CONCENTRATE 47
7 ORTHOBIOLOGICS MARKET, BY APPLICATION 48
7.1 INTRODUCTION 49
7.2 OSTEOARTHRITIS AND DEGENERATIVE ARTHRITIS 50
7.3 SPINAL FUSION 51
7.4 SOFT-TISSUE INJURIES 52
7.5 FRACTURE RECOVERY 53
7.6 MAXILLOFACIAL AND DENTAL APPLICATIONS 54
8 ORTHOBIOLOGICS MARKET, BY END USER 55
8.1 INTRODUCTION 56
8.2 HOSPITALS, ORTHOPEDIC CLINICS, & AMBULATORY CARE CENTERS 57
8.3 RESEARCH & ACADEMIC INSTITUTES 58
8.4 DENTAL CLINICS AND FACILITIES 59
9 ORTHOBIOLOGICS MARKET, BY REGION 60
9.1 INTRODUCTION 61
9.2 NORTH AMERICA 62
9.2.1 US 65
9.2.2 CANADA 67
9.3 EUROPE 69
9.3.1 GERMANY 72
9.3.2 FRANCE 74
9.3.3 UK 75
9.3.4 SPAIN 77
9.3.5 ITALY 78
9.3.6 REST OF EUROPE 80
9.4 ASIA PACIFIC 81
9.4.1 JAPAN 85
9.4.2 CHINA 86
9.4.3 INDIA 87
9.4.4 REST OF ASIA PACIFIC 89
9.5 REST OF THE WORLD 91
10 COMPETITIVE LANDSCAPE 95
10.1 GLOBAL ORTHOBIOLOGICS MARKET RANKING, 2016 95
11 COMPANY PROFILES 96
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
11.1 DEPUY SYNTHES (A SUBSIDIARY OF JOHNSON & JOHNSON) 96
11.2 MEDTRONIC PLC. 100
11.3 STRYKER CORPORATION 103
11.4 ZIMMER BIOMET HOLDINGS, INC. 106
11.5 HARVEST TECHNOLOGIES CORPORATION (A TERUMO BCT COMPANY) 111
11.6 GLOBUS MEDICAL, INC. 114
11.7 ORTHOFIX INTERNATIONAL N.V. 117
11.8 RTI SURGICAL, INC. 120
11.9 K2M GROUP HOLDINGS, INC. 126
11.10 KUROS BIOSCIENCES LTD. 129
11.11 BIOVENTUS LLC 132
11.12 NUVASIVE, INC. 135
11.13 SEASPINE HOLDINGS CORPORATION 138
11.14 ARTHREX, INC. 141
11.15 XTANT MEDICAL HOLDINGS, INC. 144
*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX 148
12.1 DISCUSSION GUIDE 148
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 151
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 153
12.4 AVAILABLE CUSTOMIZATIONS 154
12.5 RELATED REPORTS 155
12.6 AUTHOR DETAILS 156

LIST OF TABLES

TABLE 1 ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 40
TABLE 2 ORTHOBIOLOGICS MARKET FOR VISCOSUPPLEMENTATION PRODUCTS,
BY REGION, 2015–2022 (USD MILLION) 41
TABLE 3 ORTHOBIOLOGICS MARKET FOR DEMINERALIZED BONE MATRICES,
BY REGION, 2015–2022 (USD MILLION) 42
TABLE 4 ORTHOBIOLOGICS MARKET FOR SYNTHETIC ORTHOBIOLOGICS,
BY REGION, 2015–2022 (USD MILLION) 43
TABLE 5 ORTHOBIOLOGICS MARKET FOR BONE MORPHOGENIC PROTEIN,
BY REGION, 2015–2022 (USD MILLION) 44
TABLE 6 ORTHOBIOLOGICS MARKET FOR ALLOGRAFTS, BY REGION,
2015–2022 (USD MILLION) 45
TABLE 7 ORTHOBIOLOGICS MARKET FOR PLASMA-RICH PROTEIN,
BY REGION, 2015–2022 (USD MILLION) 46
TABLE 8 ORTHOBIOLOGICS MARKET FOR BONE MARROW ASPIRATE CONCENTRATE,
BY REGION, 2015–2022 (USD MILLION) 47
TABLE 9 ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 49
TABLE 10 ORTHOBIOLOGICS MARKET FOR OSTEOARTHRITIS AND DEGENERATIVE ARTHRITIS, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 11 ORTHOBIOLOGICS MARKET FOR SPINAL FUSION, BY REGION,
2015–2022 (USD MILLION) 51
TABLE 12 ORTHOBIOLOGICS MARKET FOR SOFT-TISSUE INJURIES, BY REGION,
2015–2022 (USD MILLION) 52
TABLE 13 ORTHOBIOLOGICS MARKET FOR FRACTURE RECOVERY, BY REGION,
2015–2022 (USD MILLION) 53
TABLE 14 ORTHOBIOLOGICS MARKET FOR MAXILLOFACIAL AND DENTAL APPLICATIONS,
BY REGION, 2015–2022 (USD MILLION) 54
TABLE 15 GLOBAL ORTHOBIOLOGICS MARKET, BY END USER, 2015–2022 (USD MILLION) 56
TABLE 16 GLOBAL ORTHOBIOLOGICS MARKET FOR HOSPITALS, ORTHOPEDIC CLINICS, AND AMBULATORY CARE CENTERS, BY REGION, 2015–2022 (USD MILLION) 57
TABLE 17 GLOBAL ORTHOBIOLOGICS MARKET FOR RESEARCH & ACADEMIC INSTITUTES,
BY REGION, 2015–2022 (USD MILLION) 58
TABLE 18 GLOBAL ORTHOBIOLOGICS MARKET FOR DENTAL CLINICS AND FACILITIES,
BY REGION, 2015–2022 (USD MILLION) 59
TABLE 19 ORTHOBIOLOGICS MARKET, BY REGION, 2015–2022 (USD MILLION) 61
TABLE 20 ORTHOBIOLOGICS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 62
TABLE 21 NORTH AMERICA: ORTHOBIOLOGICS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 64
TABLE 22 NORTH AMERICA: ORTHOBIOLOGICS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 64
TABLE 23 NORTH AMERICA: ORTHOBIOLOGICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 65
TABLE 24 NORTH AMERICA: ORTHOBIOLOGICS MARKET, BY END USER,
2015–2022 (USD MILLION) 65
TABLE 25 US: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 66
TABLE 26 US: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 67
TABLE 27 CANADA: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 68
TABLE 28 CANADA: ORTHOBIOLOGICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 68
TABLE 29 EUROPE: ORTHOBIOLOGICS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 71
TABLE 30 EUROPE: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 71
TABLE 31 EUROPE: ORTHOBIOLOGICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 72
TABLE 32 EUROPE: ORTHOBIOLOGICS MARKET, BY END USER, 2015–2022 (USD MILLION) 72
TABLE 33 GERMANY: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 73
TABLE 34 GERMANY: ORTHOBIOLOGICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 73
TABLE 35 FRANCE: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 74
TABLE 36 FRANCE: ORTHOBIOLOGICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 75
TABLE 37 UK: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 76
TABLE 38 UK: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 76
TABLE 39 SPAIN: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 77
TABLE 40 SPAIN: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 78
TABLE 41 ITALY: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 79
TABLE 42 ITALY: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 79
TABLE 43 ROE: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 80
TABLE 44 ROE: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 81
TABLE 45 ASIA PACIFIC: ORTHOBIOLOGICS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 83
TABLE 46 ASIA PACIFIC: ORTHOBIOLOGICS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 83
TABLE 47 ASIA PACIFIC: ORTHOBIOLOGICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 84
TABLE 48 ASIA PACIFIC: ORTHOBIOLOGICS MARKET, BY END USER,
2015–2022 (USD MILLION) 84
TABLE 49 JAPAN: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 85
TABLE 50 JAPAN: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 86
TABLE 51 CHINA: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 87
TABLE 52 CHINA: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 87
TABLE 53 INDIA: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 88
TABLE 54 INDIA: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 89
TABLE 55 ROAPAC: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 90
TABLE 56 ROAPAC: ORTHOBIOLOGICS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 90
TABLE 57 ROW: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 93
TABLE 58 ROW: ORTHOBIOLOGICS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 93
TABLE 59 ROW: ORTHOBIOLOGICS MARKET, BY END USER, 2015–2022 (USD MILLION) 94
TABLE 60 GLOBAL ORTHOBIOLOGICS MARKET RANKING, BY KEY PLAYERS, 2016 95


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 16
FIGURE 2 KEY DATA FROM SECONDARY SOURCES 17
FIGURE 3 KEY DATA FROM PRIMARY SOURCES 18
FIGURE 4 BREAKDOWN OF PRIMARIES 19
FIGURE 5 BOTTOM-UP APPROACH 20
FIGURE 6 TOP-DOWN APPROACH 21
FIGURE 7 DATA TRIANGULATION 22
FIGURE 8 ASSUMPTIONS OF THE RESEARCH STUDY 23
FIGURE 9 ORTHOBIOLOGICS MARKET, BY TYPE, 2017 VS. 2022 24
FIGURE 10 ORTHOBIOLOGICS MARKET, BY APPLICATION 2017 VS. 2022 25
FIGURE 11 ORTHOBIOLOGICS MARKET, BY END USER, 2017 VS. 2022 25
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE ORTHOBIOLOGICS MARKET, 2017 26
FIGURE 13 RISING INCIDENCE OF MUSCULOSKELETAL DISEASES IS EXPECTED TO DRIVE GROWTH OF THE ORTHOBIOLOGICS MARKET DURING THE FORECAST PERIOD 27
FIGURE 14 VISCOSUPPLEMENTATION PRODUCTS SEGMENT IS EXPECTED TO DOMINATE THE ORTHOBIOLOGICS MARKET IN 2022 28
FIGURE 15 INDIA AND CHINA ARE EXPECTED TO BE THE MOST LUCRATIVE MARKETS FOR ORTHOBIOLOGICS MANUFACTURERS 29
FIGURE 16 OSTEOARTHRITIS AND DEGENERATIVE ARTHRITIS SEGMENT IS EXPECTED TO DOMINATE THE MARKET IN 2017 30
FIGURE 17 HOSPITALS, ORTHOPEDIC CLINICS, AND AMBULATORY CARE CENTERS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 31
FIGURE 18 ORTHOBIOLOGICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 32
FIGURE 19 NUMBER OF ROAD ACCIDENTS WORLDWIDE: 2010 VS. 2014 33
FIGURE 20 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050 35
FIGURE 21 VISCOSUPPLEMENTATION PRODUCTS TO DOMINATE THE ORTHOBIOLOGICS MARKET DURING THE FORECAST PERIOD 40
FIGURE 22 SPINAL FUSIONS FORM THE FASTEST-GROWING APPLICATION SEGMENT IN THE GLOBAL ORTHOBIOLOGICS MARKET 49
FIGURE 23 HOSPITALS, ORTHOPEDIC CLINICS, AND AMBULATORY CARE CENTERS TO FORM THE FASTEST-GROWING END-USER SEGMENT IN THE GLOBAL ORTHOBIOLOGICS MARKET 56
FIGURE 24 NORTH AMERICA: ORTHOBIOLOGICS MARKET SNAPSHOT 63
FIGURE 25 EUROPE: ORTHOBIOLOGICS MARKET SNAPSHOT 70
FIGURE 26 ASIA PACIFIC: ORTHOBIOLOGICS MARKET SNAPSHOT 82
FIGURE 27 ROW: ORTHOBIOLOGICS MARKET SNAPSHOT 92
FIGURE 28 JOHNSON & JOHNSON: COMPANY SNAPSHOT 96
FIGURE 29 MEDTRONIC PLC: COMPANY SNAPSHOT 100
FIGURE 30 STRYKER CORPORATION: COMPANY SNAPSHOT 103
FIGURE 31 ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT 106
FIGURE 32 TERUMO CORPORATION: COMPANY SNAPSHOT 111

FIGURE 33 GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT 114
FIGURE 34 ORTHOFIX INTERNATIONAL N.V.: COMPANY SNAPSHOT 117
FIGURE 35 RTI SURGICAL: COMPANY SNAPSHOT 120
FIGURE 36 K2M GROUP HOLDINGS, INC.: COMPANY SNAPSHOT 126
FIGURE 37 KUROS BIOSCIENCES LTD.: COMPANY SNAPSHOT 129


【レポートのキーワード】

オーソバイオロジクス、関節内補充療法、合成オーソバイオロジクス、DBM、BMP、PRP、BMAC、同種移植片

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[オーソバイオロジクスの世界市場予測(~2022年):関節内補充療法、合成オーソバイオロジクス、DBM、BMP、PRP、BMAC、同種移植片]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆